key: cord-0702006-o7brr91f authors: Calvisi, Lucia title: Hyaluronic acid delayed inflammatory reaction after third dose of SARS‐CoV‐2 vaccine date: 2022-04-12 journal: J Cosmet Dermatol DOI: 10.1111/jocd.14970 sha: 9006c4c28d5ae3b1146b87e09a3d898381bf16ee doc_id: 702006 cord_uid: o7brr91f BACKGROUND: Treatments based on hyaluronic acid represent one of the most largely used practice of esthetic medicine. In the literature, it has already been described delayed reaction after vaccine like flu vaccine mediated by T‐lymphocytes. AIM: We report three cases of dermal filler reactions following mRNA vaccination against SARS‐CoV‐2; all the patients had received the filler months or even years before the vaccine. PATIENTS: Patient one: A 60‐year–old female patient that was treated one year ago in the lip developed swelling days after getting mRNA Pfizer Biotech vaccine. She received her booster of Pfizer vaccination one week before. Patient two: A 45‐year–old female patient treated in the lip two years before developed angioedema days after getting her booster of Pfizer Biotech vaccine. In this case, it was necessary to prescribe cortisone per os. Patient three: A 40‐year‐old female patient treated for the nasolabial fold five months before developed erythema and edema after receiving the booster of Moderna Vaccine. RESULTS: As demonstrated in our three case reports, even the booster of vaccine can cause delayed inflammatory reactions in patients that have previously received fillers. CONCLUSION: Delayed inflammatory reactions in patients that have received filler in the past are uncommon and usually self‐limited. Those are the first example reported in the literature of reaction after the booster dose without any previous symptoms. In this case, a cortisone therapy was necessary with prednisolone 25 mg for three days (Figures 3 and 4 ). Pfizer, without any reaction. We examined her for seven days with a complete resolution of the symptoms (Figures 5 and 6 ). The use of dermal fillers has an increasing demand and popularity in the last few years in esthetic medicine. Usually, the procedure is quite safe and secure, although in the literature, hypersensitivity reactions have been described. Hypersensitivity reactions can be easily classified into acute and delayed. Acute or type I hypersensitivity reactions have an onset within minutes to hours from injection time and they are immunoglobulin-E-mediated. Delayed or type IV hypersensitivity reactions can take place from 24 h to months after allergen contact. Delayed-type hypersensitivity reaction to dermal fillers is a very rare complication that usually presents as a tender, erythematous swelling. It is a cell-mediated hypersensitivity reaction caused by T-lymphocytes. 1 In our case reports, we have delayed hypersensitivity reactions because they occur days after the vaccine. When a reaction occurs, all the authors in the literature suggest a waiting approach, as we did in our cases except one, the second where it was necessary to take oral prednisolone for three days. Some other authors have reported similar reaction to SARS-CoV-2 vaccine, but none with the booster dose without previous symptoms with the others [2] [3] [4] [5] [6] [7] Probably, in these cases, the first two doses have activated the immune system with a reaction between the hyaluronic acid filler and the SARS-CoV-2 vaccine. We have presented three cases of a COVID-19 spike protein triggered inflammatory reaction to dermal HA filler. Prevention of delayed or type IV hypersensitivity reactions should include a thorough history and patient education and a window waiting between the vaccine and the dermal filler. These kind of reactions are very rare, and previous fillers are not a contraindication for the SARS-CoV-2 vaccine. The authors declared no potential conflict of interest to this article. The participants provide their written informed consent to participate in this study. The Declaration of Helsinki was adequately addressed. The data that support the findings of this study are openly available in osmond at https://pubmed.ncbi.nlm.nih.gov/34706 150/ https://orcid.org/0000-0002-2027-3749 Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm Fight against COVID-19 with mRNA vaccines and interaction with dermal fillers COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment Reaction to dermal filler following COVID-19 vaccination Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination -a case report Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 Addressing the safety of hyaluronic acid dermal filler injections during the SARS CoV-2 pandemic worldwide vaccination